Nike shares dropped sharply after the sportswear giant reported its second consecutive quarterly decline in gross margins, highlighting the challenges of its ongoing turnaround as weak sales in China, higher tariffs, and strategic shifts continue to pressure profitability. The results, while slightly better than management’s earlier expectations, underscored that Nike’s recovery remains incomplete and expensive.
For the quarter ended November 30, Nike’s gross margin fell by 300 basis points, and the company warned that margins could decline another 175 to 225 basis points in the current quarter. Sales in China fell 17%, marking the sixth straight quarterly decline in the key market. Although Nike has repeatedly said that China’s recovery would lag behind North America, analysts are growing increasingly concerned about the prolonged weakness.
CEO Elliott Hill, who took over in 2024, said the company is still in the “middle innings” of its turnaround. His strategy centers on refocusing Nike on core sports such as running and football, rebuilding relationships with wholesale partners like Dick’s Sporting Goods, and shifting attention away from legacy sneaker lines toward newer products. While this approach aims to restore Nike’s cultural relevance and compete with fast-growing rivals like On and Hoka, it has come at a short-term cost to margins. Wholesale distribution typically carries lower pricing, and efforts to clear older inventory have relied heavily on discounts.
Tariffs remain another major headwind. CFO Matthew Friend reiterated that U.S. tariffs on Southeast Asian manufacturing hubs are expected to cost Nike about $1.5 billion this year, further weighing on earnings.
Despite these challenges, Nike showed some resilience. Second-quarter revenue reached $12.43 billion, beating analyst estimates, while adjusted earnings per share of 53 cents topped forecasts. However, net income fell 32% year over year, reflecting the strain on earnings power. Looking ahead, Nike expects third-quarter revenue, including the crucial holiday season, to decline in the low-single digits.
Overall, investors were left with a clear message: Nike’s turnaround is progressing unevenly, costing real money, and will take time before growth and margins fully recover.


Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Apple Turns 50: From Garage Startup to AI Crossroads
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 



